RASGRF2 and non-small cell lung carcinoma: We also identified that the six transcripts (NTF4, PTPRD-AS, ITGA11, HID1-AS1, RASGRF2-AS1, TBX2-AS1) are associated with immune and the prognosis of NSCLC.